50% off Premium Yearly

NASDAQ:INSM
Insmed (INSM) is covered by Stockchase stock experts. Read their latest opinions, ratings and top picks below.
Insmed is a American stock, trading under the symbol INSM (previously INSM-Q on Stockchase) on the NASDAQ (INSM). It is usually referred to as NASDAQ:INSM or INSM
In the last year, no analyst issued a Buy, Sell, or Hold rating on INSM (previously INSM-Q on Stockchase) on Stockchase. Read the latest expert commentary for Insmed .
Insmed was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Insmed .
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Insmed .
Insmed is covered by Stockchase experts and is worth watching.
On 2026-10-12, Insmed (INSM) stock closed at a price of $99.38.
Up 152% last year. They got FDA approval for one of their top drugs last year to treat a lung condition. It pulled back 18% last month due to a disappointing trial result in a drug. Worth watching this.